Q2 adjusted EBITDA was $13.9M. The company said it expects to continue to see strong margin performance. “We are thrilled to announce robust fiscal third quarter results, which display record sequential organic growth and additional margin acceleration, clearly illustrating that our business continues to fire on all cylinders. We are also thrilled to report that our key performance indicators have exceeded our baseline expectations and suggest strong and sustained momentum across the organization in real time. Our healthcare network’s key expansion across the United States has been driven by our continued penetration of key sales touchpoints, the successful integration and exceptional performance of our largest acquisition to date, and the strength of our core business. Our long-term growth strategy will continue to focus on driving organic volume growth, focused acquisition strategy that utilizes our proven integration process, and by leveraging upon our acquisition pipeline,” said CEO and chairman Greg Crawford.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on QIPT:
- Quipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%
- Is QIPT a Buy, Before Earnings?
- Quipt Home Medical to Participate at the 43rd Annual Canaccord Growth Conference
- Quipt Home Medical Announces Up-listing to the Toronto Stock Exchange
- Quipt Home Medical announces up-listing to the Toronto Stock Exchange